Artificial thermo-responsive membrane able to control on-off switching drug release through nude mice skin without interference from skin- penetrating enhancers

Journal of Bioactive and Compatible Polymers

Volumn 15, Issue 2, 2000, Pages 170-181

  Lin, Shan Yang ^a   Chen, Ko Shao ^b   Lin, Yih Yih ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TATUNG INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DRUG INTERACTIONS; ETHANOL; GELS; GLYCOLS; SKIN; SOLUBILITY; STRUCTURE (COMPOSITION); SULFUR COMPOUNDS;

CHOLESTERYL OLEOYL CARBONATE; NUDE MICE SKIN; ON-OFF SWITCHING DRUG RELEASE; SALBUTAMOL SULFATE; SKIN PENETRATING ENHANCERS; THERMORESPONSIVE MEMBRANE;

POLYMERIC MEMBRANES;

ALCOHOL; DRUG CARRIER; LAUROCAPRAM; PROPYLENE GLYCOL; SALBUTAMOL SULFATE;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG TRANSPORT; MEMBRANE STRUCTURE; MEMBRANE TRANSPORT; MOUSE; NONHUMAN; SKIN PENETRATION;

EID: 0034034126     PISSN: 08839115     EISSN: None     Source Type: Journal    
DOI: 10.1106/FLXU-QHXE-NABE-TPA0     Document Type: Article

References (29)

1. A. Reinberg. 1988. A. New concepts in chronopharmacology. News Physiol. Sci., 3: 84.
2. B. Lemmer. 1991. Circadian rhythms and drug delivery. J. Control. Rel., 16: 63.
3. C. Focan. 1995. Circadian rhythms and cancer chemotherapy. Pharmacol. Ther., 67: 1.
4. M. H. Smlensky and G. E. D'alonzo. 1993. Medical chronobiology: Concepts and applications. Am. Rev. Respir. Dis., 147: s2.
5. B. Bruguerolle and B. Lemmer. 1993. Recent advances in chronopharmacokinetics: Methodological problems. Life Sci., 52: 1809.
6. N. Ogawa and S. Ohdo. 1992. Chronopharmacological aspects in dose-concentration-response relationship. Drug Delivery System (Japan), 7: 77.
7. A. Gazzaniga, M. E. Sangalli and F. Giordano. 1994. Oral chronotopic drug delivery systems: Achievement of time and/or site specificity. Eur. J. Pharm. Biopharm., 40: 246.
8. A. D'Emanuele. 1996. Responsive polymeric drug delivery. Clin. Pharmcokinet, 41: 241.
9. T. Okano, Y. H. Bae, H. Jacobs and S. W. Kim. 1990. Thermally on-off switching polymers for drug permeation and release. J. Control. Rel., 11: 255.
10. K. Iga. 1992. Optimum formulation of thermosensitive liposome for targeted tumor drug delivery. J. Takeda Res. Lab., 51: 45.
11. K. Ishihara and K. Matui. 1986. Glucose responsive insulin delivery system. J. Polym. Sci. Polym. Lett., 24: 413.
12. S. Sato, S. Y. Jeong, J. C. McRea and S. W. Kim. 1984. Self-regulating insulin delivery system II: in vivo studies. J. Control. Rel., 1: 67.
13. Y. Y. Lin, K. S. Chen and S. Y. Lin. 1996. Development and investigation of a thermo-responsive cholesteryl oleoyl carbonate-embedded membrane. J. Control. Rel., 41: 163.
14. S. Y. Lin, Y. Y. Lin and K. S. Chen. 1996. Permeation behavior of salbutamol sulfate through hydrophilic and hydrophobic membranes embedded by thermo-responsive cholesteryl oleoyl carbonate. Pharm. Res., 13: 914.
15. S. Y. Lin, K. S. Chen, Y. Y. Lin and M. J. Li. 1996. Cycle time of temperature exchange affecting the on-off pulsatile penetration of drug through thermo-responsive COC-embedded membrane. Pharm. Pharmacol. Lett., 6: 131.
16. S. Y. Lin, K. S. Chen and Y. Y. Lin. 1998. pH of preparations affecting the on-off drug penetration behavior through the thermo-responsive liquid crystal-embedded membrane. J. Control. Rel., 55: 13.
17. J. Traveset, V. Such, R. Gonzalo and E. Gelpi. 1980. Derivative and graphical procedures for correction of irrelevant UV spectrophotometric absorption in changeable matrixes. J. Pharm. Sci., 69: 629.
18. A. G. Davidson and H. Elsheikh. 1982. Assay of ephedrine or pseudo-ephedrine in pharmaceutical preparations by second and fourth derivative UV spectrophotometry. Analyst, 107: 879.
19. S. Y. Lin and Y. Y. Lin. 1998. Second-derivative UV spectroscopy used to assay salbutamol sulfate in the presence of skin interfering components. Chin. Pharm. J. (ROC), 50: 189.
20. K. A. Walters and J. Hadgraft. 1993. Pharmaceutical skin penetration enhancement. Marcel Dekker Inc., New York, 1993.
21. R. O. Potts and R. H. Guy. 1997. Mechanisms of transdermal drug delivery. Marcel Dekker Inc., New York, 1997.
22. R. B. Stoughton and W. D. McClure. 1983. Azone: a new non-toxic enhancer of percutaneous penetration. Drug Devel. Indus. Pharm., 9: 725.
23. J. Hadgraft. 1991. Structure activity relationships and percutaneous absorption. J. Control. Release, 15: 221.
24. J. C. Beastall, J. Hadgraft and C. Washington. 1988. Mechanism of action of Azone as a percutaneuos penetration enhancer: lipid bilayer fluidity and transition temperature effects. Int. J. Pharm., 43: 207.
25. B. W. Barry. 1983. Dermatological formulations. Marcel Dekker Inc., New York, pp. 127-233.
26. B. W. Barry. 1987. Mode of action of penetration enhancers in human skin. J. Control. Rel., 6: 85.
27. B. Forslind, S. Engstrom, J. Engblom and L. Norlen. 1997. A novel approach to the understanding of human skin barrier function. J. Dermatol. Sci., 14: 115.
28. A. H. Kennedy, G. M. Golden, C. L. Gay, R. H. Guy, M. L. Francoeur and V. H. Mak. 1996. Stratum corneum lipids of human epidermal keratinocyte air-liquid cultures: implications for barrier function. Pharm. Res., 13: 1162.
29. S. H. Yalkowsky and T. J. Roseman. 1981. Solubilization of drugs by cosolvency. In Yalkowsky, S. H. (ed.) Techniques of solubilization of drugs. Marcel Dekker Inc., New York, pp. 91-134.